top of page
Rx logo-01.png


  • Symptomatic erosive or ulcerative gastro-esophageal reflux disease (GERD)

  • Gastro-esophageal reflux disease Long-term Management (GERD maintenance)

  • Symptomatic treatment of moderate to very severe gastro-esophageal reflux disease (symptomatic GERD)

  • Active duodenal ulcer

  • Active benign gastric ulcer

  • Zollinger-Ellison syndrome

  • In combination with appropriate antibacterial therapeutic regimens for the eradication of H. pylori in patients with peptic ulcer disease


  • ​Hypersensitivity to Rabeprazole or other proton pump inhibitors

  • Use in caution with children, as there is no experience of its use in this group

Rabeprazole Sodium

Korab 20

Proton Pump Inhibitor


Each tablet contains 20 mg of Rabeprazole Sodium



  • Erosive or Ulcerative GERD: 20 mg once daily for 4 to 8 weeks

  • GERD Maintenance: maintenance dose of Korab 20 mg once daily, depending on the patient response

  • Active Duodenal Ulcer and Active Benign Gastric Ulcer: 20 mg taken once daily in the morning

  • Zollinger-Ellison syndrome: recommended starting dose of 60 mg once daily, to be titrated upwards to 120 mg / day based on individual patient needs

  • Eradication of H. pylori infection: combination of 20 mg twice daily in the morning before breakfast + clarithromycin 500 mg twice daily and amoxicillin 1g twice daily


Box of 100's

PHP 29.00 / tab
bottom of page